Health
‘Significant challenges’ ahead as vaccine rollout recalibrates – Sydney Morning Herald
NSW Health has said new advice regarding use of the AstraZeneca vaccine in people under 50 will cause “significant challenges” for the Australian rollout.
NSW Health has said new advice regarding the use of the AstraZeneca vaccine in people under 50 will cause significant challenges for the Australian rollout.
The ministry stopped delivering first doses of the AstraZeneca vaccine to eligible people aged under 50 following advice issued by vaccine advisory group ATAGI on Thursday night that they should be given the Pfizer vaccine.
More people will need to receive the Pfizer vaccine following advice from vaccine advisory group ATAGI.Credit:Edwina Pickles
…
-
Business20 hours agoZip shares rocketed 32% in August. Here’s how
-
Business22 hours agoGold price alert! Macquarie reveals its top ASX 200 gold stock as the metal hits all-time high
-
Business18 hours agoDown more than 20% this year, does Macquarie rate Boss Energy shares a buy?
-
General20 hours agoKids unknowingly targeted with AI abuse apps, images